glp-1 drug exposure pharmaceutical companies 2025 Receptor Agonist Market Size and Share GLP-1 Trends: Costs & Coverage

Zhang T, Cheng JK, Hu YM

Risk of stability and dosing accuracy GLP-1 receptor agonist medications are typically available in pre-filled injection form to deliver a precise dose

GLP-1s slow digestion

The FDA does not regulate OTC supplements with the same rigor as prescription medications, meaning efficacy claims remain largely unverified by independent clinical trials

The same drug, at a lower dose, is known as Ozempic (as in O-O-O, Ozempic ,the ubiquitous commercial that you undoubtedly hear and see on TV) and had already been approved in January 2020 for improving glucose regulation in diabetes

Finally, for diseases with conflicting data like AMD, a risk-benefit assessment framework is needed